Connect
MJA
MJA

Testosterone up. A case of disease mongering?

Annette Katelaris
Med J Aust 2012; 196 (10): 611. || doi: 10.5694/mja12.c0604

In this issue, Handelsman (doi: 10.5694/mja11.11277) describes changes in the patterns of testosterone prescribing in Australia from 1992 to 2010. He reports that there has been at least a twofold increase in total expenditure on prescriptions, taking into account inflation and population growth, and the increase in expenditure is greater than the increase in prescribing. Yet, there has been no change in the approved indications for the use of testosterone (androgen deficiency due to disorders of the hypothalamic–pituitary–testicular axis) or in the frequency of the conditions for which it is approved.

Please login with your free MJA account to view this article in full

  • Annette Katelaris

  • Medical Journal of Australia, Sydney, NSW.

Correspondence: akatelaris@mja.com.au

  • 1. Payer L. Disease-mongers: how doctors, drug companies, and insurers are making you feel sick. New York: Wiley and Sons, 1992: 292.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.